NGM Biopharmaceuticals

YTD

ALL

Why Robinhood?

You can watch NGM and buy or sell other stocks, ETFs, and their options commission-free!

About NGM

NGM Biopharmaceuticals is a privately-held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases.

CEO

David J. Woodhouse, PhD, MBA

CEODavid J. Woodhouse, PhD, MBA

Employees

—

Employees—

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2007

Founded2007

Employees

—

Employees—

NGM Key Statistics

Market cap

128.53M

Market cap128.53M

Price-Earnings ratio

-0.89

Price-Earnings ratio-0.89

Dividend yield

—

Dividend yield—

Average volume

536.23K

Average volume536.23K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$4.69

52 Week high$4.69

52 Week low

$0.6002

52 Week low$0.6002